Thndr Claps
  • U.S.
  • Egypt
  • Saudi
  • Thinkers
  • Arabic
No Result
View All Result
Thndr Claps

Thndr Claps » Saudi Claps » Health & Pharma 💉 » SPIMACO renews its agreement with Merck 💉

SPIMACO renews its agreement with Merck 💉

by Omar El Shorafa
September 20, 2022

The Clap
SPIMACO (2070) announced the signing and renewal of an agreement with the international company Merck.

The Deets
The agreement aims at licensing, supplying and joint marketing of two pharmaceuticals used in the treatment of diabetes and not dependent on insulin and manufactured partly at the company’s factory in the Qassim region.

What Now
SPIMACO owns the marketing and trademark rights for these pharmaceuticals registered under the Saudi Food and Drug Authority.

Why this Matters
The company expects that the total sales of the pharmacueticals will be around SAR 135 million during 2023 and 2024.

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)

Related Posts

Zain KSA strikes agreement with AWS 🤝
Telecommunications☎

Zain KSA strikes agreement with AWS 🤝

by Omar El Shorafa
February 7, 2023
Saudi Tadawul could cooperate with Hong Kong 👀
Tadawul 🔔

Saudi Tadawul could cooperate with Hong Kong 👀

by Omar El Shorafa
February 6, 2023
Atheeb Union profits jump in 2022 💰
Telecommunications☎

Atheeb Union profits jump in 2022 💰

by Omar El Shorafa
February 5, 2023
Mobily to participate in LEAP 2023 🤖
Tech 📲

Mobily to participate in LEAP 2023 🤖

by Omar El Shorafa
February 5, 2023
Alinma Bank’s profits jump in Q4 2022 🏦
Financial Services 🏛

Alinma Bank’s profits jump in Q4 2022 🏦

by Omar El Shorafa
February 2, 2023
Bank Aljazira’s profit grows 💰
Financial Services 🏛

Bank Aljazira’s profit grows 💰

by Omar El Shorafa
February 2, 2023

Website

Community

Blog

Learn

© Thndr. All rights reserved

No Result
View All Result
  • U.S.
  • Egypt
  • Saudi
  • Thinkers
  • Arabic

Disclaimer: Thndr does not provide investment advice, individual investors are responsible for their own decisions or can seek independent advice. The value of investments can go up and down. Thndr is a trading name of Thndr Securities Brokerage which is authorised and regulated by the Financial Regulatory Authority (FRA). Registered in Egypt (no. 804)..© Thndr. All rights reserved

 

Hello👋 We want you to be able to express your opinions on anything and everything finance and economics related to the Egyptian and US markets.

This is why we introduced Thndr Thinkers💭

Let’s go through some housekeeping notes before you jump into publishing your article to all Thndr Claps readers!

Type of Content📝 We want to see market-relevant content that shows good analysis, please! Base your articles on facts 

Don’t be shy, explain🗣 Flex your knowledge to us, and we’ll share it with all the readers!

Be Original🙏 Please don’t copy. No one likes a copycat. All submissions are welcome as long as they’re yours 

Make your title attractive🤩 A title is like the cover of your book. Attractive enough to make you look at the book but also clear enough to tell you what the book is about.

Clean🧹 We’re all humans and we all make mistakes. But please try and clean up the article so it’s clear for all the readers 

No promotional content🚫 We don’t publish promotional content.

Any questions about becoming a Thndr Thinker? Email thndrclaps@thndr.app and we’d be happy to help!

Normally, your article will be published within 24 hours of submission (if you followed the guidelines)